# Phase Ⅱ Clinical Trial of 24-valent Pneumococcal Polysaccharide Conjugate Vaccine

> **NCT07035054** · PHASE2 · COMPLETED · sponsor: **Jiangsu Province Centers for Disease Control and Prevention** · enrollment: 992 (actual)

## Conditions studied

- Streptococcus Pneumoniae Pneumonia

## Interventions

- **BIOLOGICAL:** low dose-1
- **BIOLOGICAL:** low dose-2
- **BIOLOGICAL:** high dose
- **BIOLOGICAL:** positive control

## Key facts

- **NCT ID:** NCT07035054
- **Lead sponsor:** Jiangsu Province Centers for Disease Control and Prevention
- **Sponsor class:** NETWORK
- **Phase:** PHASE2
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2024-04-20
- **Primary completion:** 2024-11-30
- **Final completion:** 2024-11-30
- **Target enrollment:** 992 (ACTUAL)
- **Last updated:** 2025-06-24


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT07035054

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT07035054, "Phase Ⅱ Clinical Trial of 24-valent Pneumococcal Polysaccharide Conjugate Vaccine". Retrieved via AI Analytics 2026-07-27 from https://api.ai-analytics.org/clinical/NCT07035054. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*